Feature Channels: Heart Disease

Filters close
Released: 23-Oct-2024 4:50 PM EDT
Pesquisadores da Mayo Clinic utilizam terapia com feixe de prótons para tratar distúrbio do ritmo cardíaco
Mayo Clinic

A radioterapia é um tratamento comum para o câncer, mas ela poderia também ajudar a tratar ritmos cardíacos nocivos? A Mayo Clinic concluiu recentemente o primeiro ensaio clínico em humanos utilizando a terapia com feixe de prótons, um tipo de radiação para tratar pacientes com arritmias potencialmente fatais. Os pesquisadores afirmam que os resultados iniciais são encorajadores.

Released: 23-Oct-2024 4:25 PM EDT
Investigadores de Mayo Clinic utilizan la terapia con haz de protones para tratar trastorno del ritmo cardíaco
Mayo Clinic

La radioterapia es un tratamiento común para el cáncer, ¿pero también podría ayudar a tratar los ritmos cardíacos perjudiciales? Mayo Clinic recientemente concluyó el primer ensayo clínico en humanos utilizando la terapia con haz de protones, un tipo de radiación para tratar a pacientes con arritmias potencialmente mortales. Los investigadores afirman que los resultados iniciales son alentadores.

Released: 23-Oct-2024 4:25 PM EDT
Mayo Clinic Researchers Use Proton Beam Therapy to Treat Heart Rhythm Disorder
Mayo Clinic

Radiation therapy is a common treatment for cancer, but could it also help treat dangerous heart rhythms? Mayo Clinic recently completed the first clinical trial in humans using proton beam therapy, a type of radiation, to treat patients with potentially life-threatening arrhythmias. They say initial results are encouraging.

Released: 23-Oct-2024 12:55 PM EDT
CRF® Announces 2024 SET-10 Rankings
Cardiovascular Research Foundation (CRF)

The Cardiovascular Research Foundation® (CRF®) is proud to unveil the 2024 SET-10 (Scientific Excellence Top 10), recognizing the academic and medical institutions making the most impactful contributions to interventional cardiovascular research at TCT® 2024 (Transcatheter Cardiovascular Therapeutics®), the annual scientific symposium of CRF®.

access_time Embargo lifts in 2 days
This news release is embargoed until 24-Oct-2024 11:00 AM EDT Released to reporters: 23-Oct-2024 11:15 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Oct-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Immunotherapy Blocks Scarring, Improves Heart Function in Mice with Heart Failure
21-Oct-2024 2:00 PM EDT
Immunotherapy Blocks Scarring, Improves Heart Function in Mice with Heart Failure
Washington University in St. Louis

Researchers at WashU Medicine have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment, similar to one approved by the FDA for other conditions. The findings point to the possibility of developing such immunotherapies for heart failure in patients who have experienced a heart attack or other injury.

14-Oct-2024 2:45 PM EDT
Women More Likely Than Men to Die After Heart Surgery Complications
Michigan Medicine - University of Michigan

Despite having no greater chance of developing problems after high risk cardiovascular surgery, women are more likely than men to die from postoperative complications, a University of Michigan-led study suggests. The quality of a hospital where the procedure was performed did not affect the disparity between sexes. Researchers say the "failure to rescue" is an issue for the entire United States health care system.

Not for public release

This news release is embargoed until 14-Oct-2024 5:00 PM EDT Released to reporters: 8-Oct-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Oct-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Non-Invasive Eye Test for Multiple Diseases to Advance Under $4.8m NIH Award
Released: 11-Oct-2024 3:05 PM EDT
Non-Invasive Eye Test for Multiple Diseases to Advance Under $4.8m NIH Award
Indiana University

Researchers at the IU School of Optometry and IU Luddy School of Informatics, Computing and Engineering will advance next-generation technology that uses a simple eye scan to assist in the early detection of conditions such as Alzheimer’s disease, diabetes and heart disease.

Released: 10-Oct-2024 3:05 PM EDT
MSU Research Advances Infusion Designed to Clean Arteries
Michigan State University

Inflammation of the arteries is a primary precursor and driver of cardiovascular disease — the No. 1 killer of people in the United States. This inflammation is associated with the buildup of dangerous plaque inside the arteries. Advanced treatments are needed to target this inflammation in patients. Michigan State University researchers have tested a new nanoparticle nanotherapy infusion that precisely targets inflammation and activates the immune system to help clear out arterial plaque.

Released: 10-Oct-2024 8:00 AM EDT
Lactic Acid Helps Blood Vessels Relax, Could Improve Muscle and Heart Health
American Physiological Society (APS)

A new study in rats shows that lactate, a substance found in the muscles, initiates a cascade of actions in the muscles that helps blood vessels relax. The surprising results are published ahead of print in the journal Function.

Newswise: History of COVID-19 Doubles Long-term Risk of Heart Attack, Stroke and Death
7-Oct-2024 9:05 AM EDT
History of COVID-19 Doubles Long-term Risk of Heart Attack, Stroke and Death
Cleveland Clinic

Cleveland: A history of COVID-19 can double the risk of heart attack, stroke or death according to new research led by Cleveland Clinic and the University of Southern California. The study found that people with any type of COVID-19 infection were twice as likely to have a major cardiac event, such as heart attack, stroke or even death, for up to three years after diagnosis.

Newswise: Ochsner Children’s Hospital Named No.1 Hospital for Kids in Louisiana for Fourth Consecutive Year
Released: 8-Oct-2024 8:30 AM EDT
Ochsner Children’s Hospital Named No.1 Hospital for Kids in Louisiana for Fourth Consecutive Year
Ochsner Health

For the fourth year running, Ochsner Children’s Hospital upholds its position as the No. 1 hospital for kids in Louisiana according to the 2024-2025 Best Children’s Hospital rankings by U.S. News & World Report.

Newswise: The Epileptic Heart: Seizures, Epilepsy, and Cardiac Risk Factors
Released: 2-Oct-2024 11:05 AM EDT
The Epileptic Heart: Seizures, Epilepsy, and Cardiac Risk Factors
International League Against Epilepsy

Studies suggest that compared with the general population, people with chronic epilepsy have three times the risk of sudden cardiac death. Researchers have introduced the concept of the "epileptic heart" as "a heart and coronary vasculature damaged by chronic epilepsy... leading to electrical and mechanical dysfunction."

Newswise: Global Study Highlights the Life-Saving Impact of Guideline-Directed Medical Therapy (GDMT) in Heart Failure Patients
30-Sep-2024 10:25 AM EDT
Global Study Highlights the Life-Saving Impact of Guideline-Directed Medical Therapy (GDMT) in Heart Failure Patients
University of California, Los Angeles (UCLA), Health Sciences

New UCLA-led research highlights the important role that the Guideline-Directed Medical Therapy can play in reducing mortality rates for individuals suffering from heart failure with reduced ejection fraction (HFrEF), a type of heart failure affecting an estimated 29 million people worldwide.

Released: 1-Oct-2024 8:05 AM EDT
Study Highlights Pervasiveness of Inflammation in American Diet
Ohio State University

Almost six in 10 Americans have pro-inflammatory diets, increasing the risk of health problems including heart disease and cancer, according to a new study that used a tool designed to examine inflammation in the diet.

Not for public release

This news release is embargoed until 30-Sep-2024 5:00 PM EDT Released to reporters: 24-Sep-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Study: Time-Restricted Eating May Improve Health of Adults with Metabolic Syndrome
30-Sep-2024 5:00 PM EDT
Study: Time-Restricted Eating May Improve Health of Adults with Metabolic Syndrome
UC San Diego Health

Researchers at UC San Diego School of Medicine find that limiting food consumption within a 10-hour window each day improved key markers of heart health.

Newswise: Presence of Subclinical Atherosclerosis Is Marker of Mortality and Its Progression Increases Risk of Death
30-Sep-2024 8:00 AM EDT
Presence of Subclinical Atherosclerosis Is Marker of Mortality and Its Progression Increases Risk of Death
Mount Sinai Health System

Mount Sinai study also shows imaging for early detection and monitoring can improve prediction and prevention of premature death

Newswise: Heart Transplant Patients From Socioeconomically Deprived Areas Face Higher Risk for Postoperative Complications, Earlier Death Than Others
26-Sep-2024 4:05 PM EDT
Heart Transplant Patients From Socioeconomically Deprived Areas Face Higher Risk for Postoperative Complications, Earlier Death Than Others
University of California, Los Angeles (UCLA), Health Sciences

Heart transplant patients who live in socioeconomically disadvantaged areas are more likely to experience post-surgical complications and die within five years than patients who live in more advantaged areas, even when those patients were transplanted at topnotch high-volume hospitals.



close
3.02148